| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. | Chief Business Officer | Common Stock | 613K | $9.02M | $14.73 | 16 Jun 2025 | Direct |
| Eton Pharmaceuticals, Inc. | Chief Business Officer | Restricted Stock Units | 25.9K | $207K | $7.98 | 03 Jan 2025 | Direct |
| Eton Pharmaceuticals, Inc. | Chief Business Officer | Employee Stock Option (Right to Buy) | 38.6K | 03 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals, Inc. | 12 Jun 2025 | 3 | -$504K | 4 | Chief Business Officer | 16 Jun 2025, 16:56 |
| ETON | Eton Pharmaceuticals, Inc. | 03 Jan 2025 | 2 | $0 | 4 | Chief Business Officer | 06 Jan 2025, 16:16 |
| ETON | Eton Pharmaceuticals, Inc. | 02 Oct 2024 | 1 | $0 | 4 | Chief Business Officer | 04 Oct 2024, 16:19 |
| ETON | Eton Pharmaceuticals, Inc. | 13 Feb 2024 | 1 | $0 | 4 | Chief Business Officer | 15 Feb 2024, 16:17 |
| ETON | Eton Pharmaceuticals, Inc. | 01 Mar 2023 | 0 | $0 | 3 | Chief Business Officer | 08 Mar 2023, 13:39 |